VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2
receptor-dependent pathways
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 175, Issue 19, Pages 3813-3831
Publisher
Wiley
Online
2018-07-23
DOI
10.1111/bph.14450
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery
- (2017) Alicia Bort et al. Molecular Pain
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
- (2017) Kelly L. Walton et al. Frontiers in Pharmacology
- Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
- (2016) Nadira Ruzehaji et al. ANNALS OF THE RHEUMATIC DISEASES
- Cannabinoids and autoimmune diseases: A systematic review
- (2016) Valeria Katchan et al. AUTOIMMUNITY REVIEWS
- Two Janus Cannabinoids That Are Both CB 2 Agonists and CB 1 Antagonists
- (2016) Amey Dhopeshwarkar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Comparison of collagen content in skin wounds evaluated by biochemical assay and by computer-aided histomorphometric analysis
- (2016) Guilherme F. Caetano et al. PHARMACEUTICAL BIOLOGY
- Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies
- (2016) Michele M. Luchetti et al. Arthritis & Rheumatology
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synthesis, pharmacological evaluation and docking studies of pyrrole structure-based CB 2 receptor antagonists
- (2015) Giulio Ragusa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Role of PPAR Gamma in Systemic Sclerosis
- (2015) Andréa Tavares Dantas et al. PPAR Research
- Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin-Positive Intradermal Progenitors
- (2015) Roberta Goncalves Marangoni et al. Arthritis & Rheumatology
- Pathogenesis of Systemic Sclerosis
- (2015) Debendra Pattanaik et al. Frontiers in Immunology
- Autoantibodies in Systemic Sclerosis: Unanswered Questions
- (2015) Cristiane Kayser et al. Frontiers in Immunology
- An alternate binding site for PPARγ ligands
- (2014) Travis S. Hughes et al. Nature Communications
- A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
- (2013) Jun Wei et al. ANNALS OF THE RHEUMATIC DISEASES
- Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver
- (2013) Adrien Guillot et al. HEPATOLOGY
- Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
- (2013) Adrian J Gilbane et al. ARTHRITIS RESEARCH & THERAPY
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
- (2012) Estrella Garcia Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Update on Cardiovascular Safety of PPARgamma Agonists and Relevance to Medicinal Chemistry and Clinical Pharmacology
- (2012) Andreea Ciudin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- MEK inhibition suppresses the development of lung fibrosis in the bleomycin model
- (2011) Maria Galuppo et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Real-Time PyMOL Visualization for Rosetta and PyRosetta
- (2011) Evan H. Baugh et al. PLoS One
- MEK/ERK inhibitors: proof-of-concept studies in lung fibrosis
- (2011) Andrew Leask Journal of Cell Communication and Signaling
- Anti-endothelial cell antibodies in systemic sclerosis
- (2010) C Mihai et al. ANNALS OF THE RHEUMATIC DISEASES
- Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
- (2010) Sieglinde Marquart et al. ARTHRITIS AND RHEUMATISM
- Animal models of systemic sclerosis: Prospects and limitations
- (2010) Christian Beyer et al. ARTHRITIS AND RHEUMATISM
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
- (2010) Lalit S Doshi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
- (2009) Minghua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Peroxisome proliferator-activated receptor-γ abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator
- (2009) Asish K. Ghosh et al. FASEB JOURNAL
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
- (2009) E. Garcia-Gonzalez et al. RHEUMATOLOGY
- Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4
- (2008) Serena Fineschi et al. ARTHRITIS AND RHEUMATISM
- PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
- (2007) Jami E. Milam et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now